Global Cannabidiol Supplements Market Size By Type (Hemp-derived Type, Marijuana-derived Type), By Application (Retail Pharmacies, Hospital Pharmacies), By Region, And Segment Forecasts, 2023 to 2032

The Global Cannabidiol (CBD) Supplements Market was valued at USD 5.2 billion in 2023 and is projected to reach USD 13.4 billion by 2031, expanding at a CAGR of 12.6% during the forecast period from 2023 to 2031. This robust growth is attributed to increasing consumer awareness about the health benefits of CBD, a significant rise in demand for natural health supplements, and the global trend toward wellness and preventive healthcare. With growing regulatory acceptance and the mainstreaming of cannabis-derived products, the CBD supplements market is witnessing rapid product innovation and diversified end-use applications.

Drivers:

1. Rising Awareness of Health and Wellness:

Consumers are increasingly shifting toward plant-based and natural health solutions. CBD supplements are gaining popularity due to their potential benefits in managing anxiety, sleep disorders, chronic pain, and inflammation.

2. Expanding Legalization and Regulatory Support:

Global regulatory landscapes are evolving favorably, particularly in North America and parts of Europe, leading to higher consumer access and product availability.

3. Growing Demand for Functional Food and Beverages:

The infusion of CBD into everyday consumables, such as protein bars, soft gels, and drinks, has boosted consumer interest and widened the market reach.

Restraints:

1. Regulatory Ambiguity Across Regions:

While many countries have started to legalize CBD, inconsistencies in rules concerning the use of CBD in supplements continue to challenge market penetration in some geographies.

2. Limited Clinical Validation:

Despite widespread anecdotal evidence, the lack of large-scale, peer-reviewed studies has kept some health professionals and consumers cautious about regular usage.

Opportunity:

1. Product Innovation Across Delivery Formats:

Opportunities abound in novel delivery systems such as gummies, nanoemulsion-based tinctures, capsules, and patches that enhance bioavailability and user convenience.

2. Growing Senior Demographic & Pet Applications:

CBD supplements tailored for the elderly and pets are gaining traction, representing new market frontiers with strong purchasing intent and minimal price sensitivity.

Market by System Type Insights:

By formulation type, the Capsules and Softgels segment held the largest share in 2023, favored for its ease of consumption and precise dosage control. The Gummies segment, however, is expected to witness the highest CAGR through 2031, supported by taste preference, convenience, and broad acceptance among new users.

Market by End-use Insights:

In terms of end use, the Adult segment dominated the market in 2023, driven by rising stress levels and interest in alternative health solutions. Meanwhile, the Senior segment is poised for rapid growth owing to the increasing use of CBD for age-related conditions such as arthritis, insomnia, and neuropathic pain.

Market by Regional Insights:

North America led the global CBD supplements market in 2023, accounting for the largest share due to supportive legislation, high consumer awareness, and a thriving cannabis industry. The Asia-Pacific region is projected to grow at the fastest rate, fueled by evolving regulations, expanding e-commerce platforms, and rising wellness trends in countries like Japan, South Korea, and Thailand.

Competitive Scenario:

Key players in the Global Cannabidiol Supplements Market include Charlotte’s Web Holdings, Inc., CV Sciences, Inc., Medterra CBD, Elixinol Wellness Limited, Green Roads, and Garden of Life. Companies are focusing on vertical integration, premium branding, and developing pharmaceutical-grade products to differentiate and expand their market footprint.

Scope of Work – Global Cannabidiol Supplements Market

Key Market Developments:

2023: Charlotte’s Web launched a new line of organic, NSF-certified CBD capsules targeting sleep and joint health.

2024: Medterra partnered with a major pharmacy chain to distribute its CBD gummies and tinctures across the U.S.

2025: CV Sciences introduced CBD-based nootropics targeting stress relief and cognitive enhancement.

FAQs:

1) What is the current market size of the Global Cannabidiol Supplements Market?

The market was valued at USD 5.2 billion in 2023.

2) What is the major growth driver of the Global Cannabidiol Supplements Market?

The primary driver is the rising global awareness of the health and wellness benefits associated with CBD supplements.

3) Which is the largest region during the forecast period in the Global Cannabidiol Supplements Market?

North America remains the largest region due to strong consumer demand and supportive regulation.

4) Which segment accounted for the largest market share in the Global Cannabidiol Supplements Market?

The Capsules and Softgels segment held the largest market share in 2023.

5) Who are the key market players in the Global Cannabidiol Supplements Market?

Key players include Charlotte’s Web Holdings, CV Sciences, Medterra CBD, Green Roads, and Elixinol Wellness.